Cite
MLA Citation
Amer Assal et al.. “Analysis of chronic myelogenous leukemia in an underserved, inner-city cohort shows a significant five year overall survival that is not affected by choice of tyrosine kinase inhibitor.” Leukemia & lymphoma, vol. 57, no. 10, n.d., pp. 2452–2455. http://access.bl.uk/ark:/81055/vdc_100034959453.0x00003c